Helle Linnebjerg Selected Research

Helle Linnebjerg Research Topics

12	Type 2 Diabetes Mellitus (MODY) 03/2022 - 10/2006
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 01/2017
2	Aortic Valve Stenosis (Aortic Stenosis) 12/2023 - 01/2023
2	Chronic Kidney Failure (Chronic Renal Failure) 05/2016 - 09/2007
2	Hypoglycemia (Reactive Hypoglycemia) 09/2014 - 06/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2023
1	Weight Loss (Weight Reduction) 01/2018
1	Insulin Resistance 01/2017
1	Pain (Aches) 07/2015
1	Body Weight (Weight, Body) 06/2013
1	Vomiting 09/2007
1	Nausea 09/2007

8	Exenatide (Byetta)FDA Link 06/2013 - 10/2006
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2009
7	Insulin (Novolin)FDA Link 03/2022 - 09/2014
5	Insulin Lispro (Humalog)FDA Link 01/2023 - 10/2020
4	basal insulin peglisproIBA 01/2018 - 05/2016
4	Insulin Glargine (Lantus)FDA Link 01/2018 - 01/2017
2	Lipoprotein(a)IBA 12/2023 - 01/2023
2	LipidsIBA 01/2018 - 01/2018
2	CreatinineIBA 05/2016 - 09/2007
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Ketone BodiesIBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	VLDL LipoproteinsIBA 01/2018
1	LY2963016 insulin glargineIBA 01/2017
1	LY2605541IBA 05/2016
1	Blood Glucose (Blood Sugar)IBA 11/2012
1	Glucagon (Glukagon)FDA Link 11/2012
1	Glucagon-Like Peptide-1 ReceptorIBA 11/2012
1	Hemoglobin AIBA 01/2009
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2009
1	BiguanidesIBA 01/2009
1	Pharmacologic ActionsIBA 10/2006

3	Injections 07/2015 - 03/2012
1	Subcutaneous Injections 03/2022
1	Renal Dialysis (Hemodialysis) 05/2016
1	Intramuscular Injections 07/2015
1	Glycemic Control 06/2013